Thermo Fisher Scientific (TMO) Net Cash Flow Growth (3y) (2012 - 2026)
Thermo Fisher Scientific (TMO) Net Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.68 Bn | 209.62 Bn | 8.34 Bn | 58.74% |
| 2 | Danaher | 140.36 Bn | 136.01 Bn | 3.61 Bn | -43.12% |
| 3 | Idexx Laboratories | 46.24 Bn | 46.05 Bn | 779.09 Mn | -29.30% |
| 4 | Agilent Technologies | 39.65 Bn | 37.84 Bn | 990.00 Mn | 41.14% |
| 5 | Iqvia Holdings | 39.23 Bn | 37.15 Bn | 1.44 Bn | 27.97% |
| 6 | Natera | 38.88 Bn | 37.78 Bn | 696.04 Mn | 29.81% |
| 7 | Illumina | 30.04 Bn | 28.87 Bn | 770.00 Mn | -40.43% |
| 8 | Mettler Toledo International | 28.62 Bn | 28.57 Bn | 650.22 Mn | -38.01% |
| 9 | Quest Diagnostics | 26.22 Bn | 25.59 Bn | 1.03 Bn | 89.23% |
| 10 | Labcorp Holdings | 25.83 Bn | 24.85 Bn | 1.01 Bn | 138.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 58.74% |
| Mar 28, 2026 | -10.07% |
| Dec 31, 2025 | 13.73% |
| Sep 27, 2025 | -59.10% |
| Jun 28, 2025 | 29.08% |
| Mar 29, 2025 | 27.20% |
| Dec 31, 2024 | 64.21% |
| Sep 28, 2024 | -35.95% |
| Jun 29, 2024 | 1.44% |
| Mar 30, 2024 | 18.88% |
| Dec 31, 2023 | -10.36% |
| Sep 30, 2023 | 25.78% |
| Jul 1, 2023 | -28.62% |
| Apr 1, 2023 | -108.02% |
| Dec 31, 2022 | 71.57% |
| Oct 1, 2022 | 48.98% |
| Jul 2, 2022 | -38.47% |
| Apr 2, 2022 | -19.01% |
| Dec 31, 2021 | -110.15% |
| Oct 2, 2021 | 206.63% |